An analysis for recent years' innovative drug registration applications in ChinaZHANG Xiao-dong, WANG Hong-liang, YANG Zhi-min2041-2045
Discussion on the issues of batch size for registration of chemical drugWANG Hong-liang, CHEN Zhen2046-2051
Non-clinical safety considerations for the development of pediatric drugsHUANG Fang-hua, WANG Qing-li, Jim Ridings, WANG Ying, ZHANG Yun2052-2058
Formal dispute resolution of drug review in the United State and its implications for ChinaGENG Xiao-ya, WEI Tian-ying, MA Kun2059-2066
Influence of new registration on chemical generic drug R&D and registration managementJIANG Yu2067-2073
Endpoints and common methods for assessing efficacy in clinical trials of new drugsLIU Bing-lin2074-2077
Consideration on protecting the rights of subjects with mental disease in drug clinical trialsCHANG Mai-hui, GENG Ying, ZHAO De-heng, YANG Zhi-min2078-2081
Brief introduction of pivotal clinical trials for the human papillomavirus vaccines approved abroadAI Xing, WANG Zhao-yun, YANG Zhi-min, YANG Huan2085-2089